About Eisai Innovation
Eisai Innovation is a private equity firm founded in 2019. It is primarily based in Cambridge, United States. As of Aug 2026, Eisai Innovation is an active investor with a portfolio of 24 companies, comprising 24 funding rounds and 1 acquisition. In the last 12 months, it has participated in 3 funding rounds. The firm primarily invests in companies based in United States and Japan. Its portfolio is spread across a wide range of sectors from Life Sciences to HealthTech. Its latest investment was a $***** Series A round in Vivacta Biotechnology on Apr 29, 2026 which also saw participation from Loayal Valley Capital, Decheng Capital and other investors.
Overall Eisai Innovation portfolio has seen 1 unicorn, 2 IPOs and 2 acquisitions including key companies like Oura, Prism Biolab and Caraway Therapeutics. A lot of funds co-invest with Eisai Innovation, with names like Elysian Park sharing a substantial percentage of its portfolio.
Key Metrics
Founded Year
2019
Location
Cambridge, United States
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Eisai Innovation's Portfolio
Eisai Innovation has a portfolio of 24 companies. They have invested in a total of 24 companies. Their most recent investment was in Vivacta Biotechnology (Series A round) on Apr 29, 2026. Here is the most recent investment by Eisai Innovation:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Apr 29, 2026 | Series A | 1231 | ||
Mar 18, 2026 | Seed | 6912 | ||
Nov 25, 2025 | Seed | 5944 | ||
Sep 04, 2024 | Series D | 3971 | and 9 others |
Eisai Innovation has acquired 1 company. Their most recent acquisition was of Arteryex on Apr 01, 2022. Here is the most recent acquisition by Eisai Innovation:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Apr 01, 2022 | Mobile-based platform for enterprise data management | - | 2018 |
Here is the portfolio snapshot of Eisai Innovation:
Investments by Year
The maximum number of investments were made in 2020
Acquisitions by Year
The maximum number of acquisitions were made in 2022
Portfolio by Location
Companies are primarily in United States and Japan
Portfolio by Sector
Companies are primarily in Life Sciences
Co-investors of Eisai Innovation
Over the past 7 years, 60 investors have co-invested in Eisai Innovation's portfolio companies.
- Top Co-investors of Eisai Innovation: 60 investors entered a company along with Eisai Innovation. These include investors like Elysian Park (1 company).
Eisai Innovation News
•
Vivacta Bio Secures Over $50 Million in Series A and A+ FinancingPR Newswire•Apr 29, 2026•Loayal Valley Capital, Decheng Capital, Vivacta Biotechnology, Eisai Innovation and 3 others
•
Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed FinancingBusinessFortNight•Feb 18, 2026•Valuence Ventures, FreeFlow, Plug and Play Tech Center, LifeSpan Vision Ventures and 5 others
•
•
Hyku Biosciences is launching with $56 million to boost its covalent drug platformEl Confidencial Digital•Sep 19, 2023•Hyku Biosciences, RA Capital Management, Droia Ventures, Novartis Venture Fund and 3 others
